IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.
Encarnación Donoso-NavarroIgnacio Arribas GómezFrancisco A Bernabeu-AndreuPublished in: Biomarker insights (2021)
Age, LDH, IL-6 and lymphocyte count, as independent predictors of death, could be used to establish more aggressive therapies in COVID-19 patients.